Weeks after Merck & Co. scrapped development of its Covid-19 vaccines in January, one of its senior manufacturing officials began phoning his deputies, telling them their work on a pandemic shot wasn’t actually over. J&J’s unusual collaboration with a rival, and Merck’s speedy manufacturing run-up, reflect one of the biggest challenges of the pandemic: making enough Covid-19 vaccines to meet …
GAMPELA, Burkina Faso — The chain breaks here, in a tiny medical clinic in Burkina Faso that went nearly a year without a working refrigerator. But despite enormous strides in equipping developing countries to maintain the vaccine “cold chain,” nearly 3 billion of the world’s 7.8 billion people live where temperature-controlled storage is insufficient for an immunization campaign to bring …
The agreement will help UK address a key challenge in supply that vaccine makers are likely to face — shortage of vials to rapidly ‘fill and finish’ tens of thousands of vaccine doses. Mumbai-based pharmaceutical and biotechnology giant Wockhardt has announced a new deal it has inked with the British government to supply millions of doses of various COVID-19 vaccines …
)